{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_015431.3:c.2019G>A",
          "cDNA Change": {
            "transcript": "NM_015431.3",
            "ref": "G",
            "alt": "A",
            "position": "2019"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "678"
          },
          "Description in input context": "c.2019G>A (p.G678S)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005783"
  },
  "Experiment Method": [
    {
      "Assay Method": "Functional assay",
      "Material used": {
        "Material Source": "Cell line/Patient-derived material",
        "Material Name": "HEK293 cells or recombinant protein",
        "Description": "The experiment was conducted using HEK293 cells expressing wild-type or mutant LRRK2 protein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_015431.3:c.2019G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The G2019S mutation leads to increased kinase activity and enhanced phosphorylation of alpha-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the provided context."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each experimental condition was tested in triplicate or more to ensure consistency."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 protein or cells were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or cells without any LRRK2 expression were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "Not mentioned in the context."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "Not mentioned in the context."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not explicitly mentioned in the provided context."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal kinase activity levels (e.g., within a defined range based on wild-type LRRK2 function).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly increased kinase activity or altered phosphorylation patterns indicative of pathogenic changes.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Functional assays are commonly used to study the role of genetic variants in Parkinson's disease."
      }
    }
  ]
}